Page last updated: 2024-11-02

pamidronate and Chronic Illness

pamidronate has been researched along with Chronic Illness in 27 studies

Research Excerpts

ExcerptRelevanceReference
"The objectives were to assess changes in radiological disease activity in children with chronic non-bacterial osteomyelitis (CNO) receiving pamidronate therapy and to test a modified radiological index for non-bacterial osteitis (mRINBO) in CNO."8.12Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. ( Andreasen, CM; Hauge, EM; Herlin, T; Jurik, AG; Klicman, RF, 2022)
"To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children."8.12Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. ( Juszczak, B; Sułko, J, 2022)
"Pamidronate use in a CCI population is associated with reduced mortality, lower hypoglycemia rates, improved albumin, and stable renal function."7.83INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS. ( Casey, MF; Godbold, JH; Mechanick, JI; Moshier, EL; Rho, L; Schulman, RC; Zaidi, M, 2016)
"There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)."7.76Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010)
"We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative."7.74Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007)
"Osteoporosis is a major complication of chronic cholestatic liver disease (CCLD)."5.38Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. ( de Paula, FJ; Defino, HL; Facincani, I; Jorgetti, V; Mattar, R; Pereira, FA; Ramalho, LN; Volpon, JB, 2012)
"The objectives were to assess changes in radiological disease activity in children with chronic non-bacterial osteomyelitis (CNO) receiving pamidronate therapy and to test a modified radiological index for non-bacterial osteitis (mRINBO) in CNO."4.12Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate. ( Andreasen, CM; Hauge, EM; Herlin, T; Jurik, AG; Klicman, RF, 2022)
"To evaluate patient-reported effectiveness, safety and social influence of Pamidronate in the therapy of NSAIDs-refractory Chronic Recurrent Multifocal Osteomyelitis in children."4.12Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children. ( Juszczak, B; Sułko, J, 2022)
"Pamidronate use in a CCI population is associated with reduced mortality, lower hypoglycemia rates, improved albumin, and stable renal function."3.83INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS. ( Casey, MF; Godbold, JH; Mechanick, JI; Moshier, EL; Rho, L; Schulman, RC; Zaidi, M, 2016)
"There are only a few studies that address the frequency and type of spinal involvement in patients with chronic recurrent multifocal osteomyelitis (CRMO) as well as the outcome of these patients treated with pamidronate (PAM)."3.76Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate. ( Dannecker, GE; Hospach, T; Langendoerfer, M; Maier, J; von Kalle, T, 2010)
"We report a juvenile case of diffuse sclerosing osteomyelitis of the mandible that showed a favorable response to pamidronate, a bisphosphonate derivative."3.74Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate. ( Ishikawa, M; Kitagawa, Y; Nomura, K; Notani, K; Satoh, C; Yamazaki, Y, 2007)
"Pamidronate appears to be an effective treatment in children with CNO unresponsive to NSAIDs."1.40Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging. ( Finn, A; Ramanan, AV; Roderick, M; Shah, R, 2014)
"Osteoporosis is a major complication of chronic cholestatic liver disease (CCLD)."1.38Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats. ( de Paula, FJ; Defino, HL; Facincani, I; Jorgetti, V; Mattar, R; Pereira, FA; Ramalho, LN; Volpon, JB, 2012)
"Five patients with CRMO, all of whom had ongoing pain and loss of function despite conventional treatment with non-steroidal anti-inflammatory agents, were treated with pamidronate (1 mg/kg/dose with a dosing frequency of 2 to 4 monthly for a total treatment duration of 12 to 42 months)."1.35Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis. ( Allen, RC; Simm, PJ; Zacharin, MR, 2008)
"A strategy that blocks localized bone resorption may prevent the progression of the disease."1.31Inhibition of cholesteatomatous bone resorption with pamidronate disodium. ( Chung, JW; Kim, HJ; Lee, SH; Park, MH; Yoon, TH, 2001)

Research

Studies (27)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (11.11)18.2507
2000's11 (40.74)29.6817
2010's7 (25.93)24.3611
2020's6 (22.22)2.80

Authors

AuthorsStudies
Abdou, WM1
Ganoub, NA1
Geronikaki, A1
Sabry, E1
Andreasen, CM1
Klicman, RF1
Herlin, T1
Hauge, EM1
Jurik, AG1
Fraleigh, R1
Wei, XC1
Yu, W1
Miettunen, PM1
Stojkic, I1
Rubin, E1
Lee, J1
Lee, ASE1
Ogbu, EA1
Kaneko, S1
Shimizu, M1
Inoue, N1
Mizuta, M1
Yachie, A1
Bhat, CS1
Chopra, M1
Andronikou, S1
Paul, S1
Wener-Fligner, Z1
Merkoulovitch, A1
Holjar-Erlic, I1
Menegotto, F1
Simpson, E1
Grier, D1
Ramanan, AV2
Juszczak, B1
Sułko, J1
Handly, B1
Moore, M1
Creutzberg, G1
Groh, B1
Mosher, T1
Roderick, M1
Shah, R1
Finn, A1
Schulman, RC1
Moshier, EL1
Rho, L1
Casey, MF1
Godbold, JH1
Zaidi, M1
Mechanick, JI2
Alons, K1
Kuijpers, SC1
de Jong, E1
van Merkesteyn, JP1
Hospach, T1
Langendoerfer, M1
von Kalle, T1
Maier, J1
Dannecker, GE1
Scoletta, M1
Arduino, PG1
Dalmasso, P1
Broccoletti, R1
Mozzati, M1
Conejo-Fernández, A1
Núñez Cuadros, E1
Jiménez Hinojosa, JM1
Urda Cardona, AL1
Pereira, FA1
Mattar, R1
Facincani, I1
Defino, HL1
Ramalho, LN1
Jorgetti, V1
Volpon, JB1
de Paula, FJ1
Pappagallo, M1
Breuer, B1
Schneider, A1
Sperber, K1
Tokumoto, T1
Tanabe, K1
Toma, H1
Akiba, T1
Duque, G1
Segal, R1
Wise, F1
Bianco, J1
Yamazaki, Y1
Satoh, C1
Ishikawa, M1
Notani, K1
Nomura, K1
Kitagawa, Y1
Compeyrot-Lacassagne, S1
Rosenberg, AM1
Babyn, P1
Laxer, RM1
Simm, PJ1
Allen, RC1
Zacharin, MR1
Sinha, RN1
Fraser, WD1
Casson, IF1
Devogelaer, JP1
Nagant de Deuxchaisnes, C1
Nierman, DM1
Yoon, TH1
Lee, SH1
Park, MH1
Chung, JW1
Kim, HJ1
Coinde, E1
David, L1
Cottalorda, J1
Allard, D1
Bost, M1
Lucht, F1
Stéphan, JL1
Spindler, A1
Berman, A1
Mautalen, C1
Ubios, J1
Santini, AE1

Reviews

2 reviews available for pamidronate and Chronic Illness

ArticleYear
Chronic recurrent multifocal osteomyelitis with myositis: A case report and review of the literature.
    Pediatrics international : official journal of the Japan Pediatric Society, 2020, Volume: 62, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Child; Chronic Disease; C

2020
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
    Clinical calcium, 2004, Volume: 14, Issue:5

    Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds

2004

Other Studies

25 other studies available for pamidronate and Chronic Illness

ArticleYear
Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Bone Resorption;

2008
Standardized reporting and quantification of whole-body MRI findings in children with chronic non-bacterial osteomyelitis treated with pamidronate.
    Pediatric rheumatology online journal, 2022, Oct-01, Volume: 20, Issue:1

    Topics: Child; Chronic Disease; Female; Humans; Magnetic Resonance Imaging; Male; Osteitis; Osteomyelitis; P

2022
Chronic recurrent multifocal osteomyelitis with a comprehensive approach to differential diagnosis of paediatric skull pain.
    BMJ case reports, 2023, Jan-04, Volume: 16, Issue:1

    Topics: Child; Chronic Disease; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Osteiti

2023
An unusual presentation of chronic recurrent multifocal osteomyelitis involving bones of the skull.
    International journal of rheumatic diseases, 2023, Volume: 26, Issue:8

    Topics: Adolescent; Child; Chronic Disease; Diagnostic Imaging; Humans; Male; Osteomyelitis; Pamidronate; Re

2023
Artificial intelligence for interpretation of segments of whole body MRI in CNO: pilot study comparing radiologists versus machine learning algorithm.
    Pediatric rheumatology online journal, 2020, Jun-09, Volume: 18, Issue:1

    Topics: Adolescent; Artificial Intelligence; Bone Density Conservation Agents; Chronic Disease; Disease Prog

2020
Patient-reported effectiveness and safety of Pamidronate in NSAIDs-refractory chronic recurrent multifocal osteomyelitis in children.
    Rheumatology international, 2022, Volume: 42, Issue:4

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Chronic Disease; Drug-Related Side Effects and Adver

2022
Bisphosphonate therapy for chronic recurrent multifocal osteomyelitis.
    Skeletal radiology, 2013, Volume: 42, Issue:12

    Topics: Adolescent; Bone Density Conservation Agents; Chronic Disease; Diphosphonates; Humans; Male; Osteomy

2013
Efficacy of pamidronate therapy in children with chronic non-bacterial osteitis: disease activity assessment by whole body magnetic resonance imaging.
    Rheumatology (Oxford, England), 2014, Volume: 53, Issue:11

    Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Diphosphonates; Dise

2014
INTRAVENOUS PAMIDRONATE IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CHRONIC CRITICAL ILLNESS.
    Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2016, Volume: 22, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Resorption; Chronic Disease;

2016
Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2009, Volume: 107, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Bone Density Conservation Agents; Chronic

2009
Spinal involvement in chronic recurrent multifocal osteomyelitis (CRMO) in childhood and effect of pamidronate.
    European journal of pediatrics, 2010, Volume: 169, Issue:9

    Topics: Adolescent; Back Pain; Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Fem

2010
Treatment outcomes in patients with bisphosphonate-related osteonecrosis of the jaws: a prospective study.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2010, Volume: 110, Issue:1

    Topics: Aged; Alcohol Drinking; Alendronate; Anti-Bacterial Agents; Bone Density Conservation Agents; Chroni

2010
[Pamidronate: a therapeutic alternative in chronic recurrent mutifocal osteomyelitis].
    Anales de pediatria (Barcelona, Spain : 2003), 2011, Volume: 75, Issue:3

    Topics: Child; Chronic Disease; Diphosphonates; Female; Humans; Osteomyelitis; Pamidronate; Recurrence

2011
Pamidronate for the treatment of osteoporosis secondary to chronic cholestatic liver disease in Wistar rats.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2012, Volume: 45, Issue:12

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Cholestasis, Intrahepatic; Chronic Disease;

2012
Treatment of chronic mechanical spinal pain with intravenous pamidronate: a review of medical records.
    Journal of pain and symptom management, 2003, Volume: 26, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Back Pain; Chronic Disease; Diphosphonates

2003
Chronic hypercalcemia as a reversible cause of cognitive impairment: improvement after a single administration of pamidronate.
    Journal of the American Geriatrics Society, 2005, Volume: 53, Issue:9

    Topics: Aged; Chronic Disease; Cognition Disorders; Diphosphonates; Female; Humans; Hypercalcemia; Hyperpara

2005
Remarkable response of juvenile diffuse sclerosing osteomyelitis of mandible to pamidronate.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 2007, Volume: 104, Issue:1

    Topics: Bone Density Conservation Agents; Child; Chronic Disease; Diphosphonates; Humans; Male; Mandibular D

2007
Pamidronate treatment of chronic noninfectious inflammatory lesions of the mandible in children.
    The Journal of rheumatology, 2007, Volume: 34, Issue:7

    Topics: Anti-Inflammatory Agents; Child; Child, Preschool; Chronic Disease; Diphosphonates; Female; Humans;

2007
Bisphosphonate treatment in chronic recurrent multifocal osteomyelitis.
    The Journal of pediatrics, 2008, Volume: 152, Issue:4

    Topics: Adolescent; Child; Chronic Disease; Diphosphonates; Female; Humans; Male; Osteomyelitis; Pamidronate

2008
Long-term management of hypercalcaemia in chronically active sarcoidosis.
    Journal of the Royal Society of Medicine, 1997, Volume: 90, Issue:3

    Topics: Adult; Chronic Disease; Diphosphonates; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Hy

1997
Use of pamidronate in chronic and acute bone loss conditions.
    Medicina, 1997, Volume: 57 Suppl 1

    Topics: Acute Disease; Bone Density; Bone Resorption; Chronic Disease; Diphosphonates; Female; Humans; Male;

1997
Biochemical response to treatment of bone hyperresorption in chronically critically ill patients.
    Chest, 2000, Volume: 118, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biomarkers; Calcitriol; Calcium; Calcium C

2000
Inhibition of cholesteatomatous bone resorption with pamidronate disodium.
    Acta oto-laryngologica, 2001, Volume: 121, Issue:2

    Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Bone Resorption; Calcium; Cholesteatoma, Middle

2001
[Chronic recurrent multifocal osteomyelitis in children: report of 17 cases].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2001, Volume: 8, Issue:6

    Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Bone and Bones; Child; Child, Pr

2001
Chronic idiopathic hyperphosphatasia. Report of a case treated with pamidronate and a review of the literature.
    The Journal of rheumatology, 1992, Volume: 19, Issue:4

    Topics: Adult; Alkaline Phosphatase; Bone and Bones; Chronic Disease; Diphosphonates; Female; Humans; Hydrox

1992